Researchmoz added Most up-to-date research on "Cardiac Maker Analyzer - Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies" to its huge collection of research reports.
Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.
Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.
Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1273820
All the 12 Cardiac Marker Analyzers in the report have been studied from 5 viewpoints.
Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.
Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.
Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1273820
All the 12 Cardiac Marker Analyzers in the report have been studied from 5 viewpoints.
- Analyzer Specifications and Benefits
- Net Product Sales
- Merger, Acquisition & Licensing Agreement
- Marketing Strategies
- Methods of Distribution
- Alere Meterpro Analyzer
- RAMP 200
- RAMP Reader
- The i–STAT System
- Cobas h 232 POC System
- Stratus CS Analyzer
- Access 2 Immunoassay System
- ichroma DUO Analyzer
- DXpress Reader Analyzer
- PATHFAST Analyzer
- Meritas POC Analyzer
- QL Care Analyzer
Table of Content
1. Executive Summary
2. Cardiac Marker Companies – Comparative Tests Analysis
3. Cardiac Marker Analyzer – Competitive Product Analysis
4. Alere
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
5. Response Biomedical
5.1 Cardiovascular Testing
5.1.1 Acute Myocardial Infarction (Heart Attack) Testing
5.1.2 Congestive Heart Failure (“CHF”) Testing
5.1.3 Thrombotic Disease Testing
5.2 RAMP Platform
5.2.1 RAMP 200
Browse More Details @ http://www.researchmoz.us/cardiac-maker-analyzer-product-analysis-business-marketing-strategy-of-cardiac-maker-companies-report.html
1. Executive Summary
2. Cardiac Marker Companies – Comparative Tests Analysis
3. Cardiac Marker Analyzer – Competitive Product Analysis
4. Alere
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
5. Response Biomedical
5.1 Cardiovascular Testing
5.1.1 Acute Myocardial Infarction (Heart Attack) Testing
5.1.2 Congestive Heart Failure (“CHF”) Testing
5.1.3 Thrombotic Disease Testing
5.2 RAMP Platform
5.2.1 RAMP 200
Browse More Details @ http://www.researchmoz.us/cardiac-maker-analyzer-product-analysis-business-marketing-strategy-of-cardiac-maker-companies-report.html
No comments:
Post a Comment